title: Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis.
abstract: This study evaluated whether renal escape from vasopressin-induced antidiuresis is associated with alterations of vasopressin V2 receptor binding in the kidney inner medulla. A radioligand binding assay was developed using a novel iodinated vasopressin V2 receptor antagonist to analyze vasopressin V2 receptor binding in kidney inner medullary tissue from three groups of rats: normal rats maintained on ad libitum water intake, rats treated with 1-deamino-[8-D-arginine]vasopressin (DDAVP), and rats treated with DDAVP that were also water loaded to induce renal escape from antidiuresis. Analysis of the binding data showed that DDAVP treatment reduced vasopressin V2 receptor binding to 72% of normal levels. Water loading induced a marked further down-regulation of vasopressin V2 receptor binding. This receptor down-regulation began by day 2 of water loading, which correlated with the initiation of renal vasopressin escape; by day 3 of water loading, vasopressin V2 receptor expression fell to 43% of DDAVP-treated levels. No differences in vasopressin V2 receptor binding affinities were found among the three groups. This study demonstrates that vasopressin V2 receptor binding capacity is down-regulated during renal escape from vasopressin-induced antidiuresis and suggests that both vasopressin-dependent mechanisms as well as vasopressin-independent mechanisms associated with water loading are involved in this receptor down-regulation.
authors.affiliation: Department of Medicine, Georgetown University, Washington, DC 20007, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Tian
authors.forename: K
authors.initials: K
authors.lastname: Sandberg
authors.forename: T
authors.initials: T
authors.lastname: Murase
authors.forename: E A
authors.initials: EA
authors.lastname: Baker
authors.forename: R C
authors.initials: RC
authors.lastname: Speth
authors.forename: J G
authors.initials: JG
authors.lastname: Verbalis
mesh_terms: D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects / Q000502:physiology*; D015536:Down-Regulation / Q000187:drug effects; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D007679:Kidney Medulla / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D008297:Male; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D017483:Receptors, Vasopressin / Q000378:metabolism*; D012964:Sodium / Q000652:urine; D014667:Vasopressins / Q000494:pharmacology*; D014867:Water / Q000378:metabolism
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D017483:Receptors, Vasopressin; D014867:Water; D014667:Vasopressins; D012964:Sodium; D003894:Deamino Arginine Vasopressin